Anti-IL1B/ IL-1/ IL1-BETA functional antibody

Anti-IL1B/ IL-1/ IL1-BETA functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IL1B/IL1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T42000-Ab-1/ GM-Tg-hg-T42000-Ab-2Anti-Human IL1B monoclonal antibodyHuman
GM-Tg-rg-T42000-Ab-1/ GM-Tg-rg-T42000-Ab-2Anti-Rat IL1B monoclonal antibodyRat
GM-Tg-mg-T42000-Ab-1/ GM-Tg-mg-T42000-Ab-2Anti-Mouse IL1B monoclonal antibodyMouse
GM-Tg-cynog-T42000-Ab-1/ GM-Tg-cynog-T42000-Ab-2Anti-Cynomolgus/ Rhesus macaque IL1B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T42000-Ab-1/ GM-Tg-felg-T42000-Ab-2Anti-Feline IL1B monoclonal antibodyFeline
GM-Tg-cang-T42000-Ab-1/ GM-Tg-cang-T42000-Ab-2Anti-Canine IL1B monoclonal antibodyCanine
GM-Tg-bovg-T42000-Ab-1/ GM-Tg-bovg-T42000-Ab-2Anti-Bovine IL1B monoclonal antibodyBovine
GM-Tg-equg-T42000-Ab-1/ GM-Tg-equg-T42000-Ab-2Anti-Equine IL1B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T42000-Ab-1/ GM-Tg-hg-T42000-Ab-2; GM-Tg-rg-T42000-Ab-1/ GM-Tg-rg-T42000-Ab-2;
GM-Tg-mg-T42000-Ab-1/ GM-Tg-mg-T42000-Ab-2; GM-Tg-cynog-T42000-Ab-1/ GM-Tg-cynog-T42000-Ab-2;
GM-Tg-felg-T42000-Ab-1/ GM-Tg-felg-T42000-Ab-2; GM-Tg-cang-T42000-Ab-1/ GM-Tg-cang-T42000-Ab-2;
GM-Tg-bovg-T42000-Ab-1/ GM-Tg-bovg-T42000-Ab-2; GM-Tg-equg-T42000-Ab-1/ GM-Tg-equg-T42000-Ab-2
Products NameAnti-IL1B monoclonal antibody
Formatmab
Target NameIL1B
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL1B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-241Pre-Made Gevokizumab biosimilar, Whole mAb, Anti-IL1B Antibody: Anti-IL-1/IL1-BETA/IL1F2/IL1beta therapeutic antibody
    BiosimilarGMP-Bios-ab-091Pre-Made Canakinumab biosimilar, Whole mAb, Anti-IL1B Antibody: Anti-IL-1/IL1-BETA/IL1F2/IL1beta therapeutic antibody
    BiosimilarGMP-Bios-INN-973Pre-Made Rilonacept Biosimilar, Fusion Protein targeting IL1B fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting IL-1/IL1-BETA/IL1F2/IL1beta
    BiosimilarGMP-Bios-ab-331Pre-Made Lutikizumab biosimilar, Bispecific Dual Variable Domain IG, Anti-IL1A;IL1B Antibody: Anti-IL1/IL-1A/IL1F1/IL1-ALPHA/IL-1 alpha;IL-1/IL1-BETA/IL1F2/IL1beta therapeutic antibody
    Target AntigenGM-Tg-g-T42000-Ag-1Recombinant multi-species IL1B/ IL-1/ IL1-BETA protein
    CytokineGM-Tg-g-T42000-Ag-1Interleukin-1 Beta (Il1b) protein
    ORF Viral VectorvGMAP000158Human IL1B Adenovirus particle
    ORF Viral VectorpGMAP000158Human IL1B Adenovirus plasmid
    ORF Viral VectorpGMAD000350rat Il1b Adenovirus plasmid
    ORF Viral VectorpGMAD000472Norway rat Il1b Adenovirus plasmid
    ORF Viral VectorvGMAD000350rat Il1b Adenovirus particle
    ORF Viral VectorvGMAD000472Norway rat Il1b Adenovirus particle


    Target information

    Target IDGM-T42000
    Target NameIL1B
    Gene ID3553,16176,24494,704701,403974,768274,281251
    Gene Symbol and SynonymsIL-1,Il-1b,IL-1beta,IL-1F2,IL1-BETA,IL1B,IL1beta,IL1F2
    Uniprot AccessionP01584,Q63264,P48090,Q28292,P41687,P09428
    Uniprot Entry NameIL1B_HUMAN,IL1B_MACMU,IL1B_RAT,IL1B_FELCA,IL1B_CANLF,IL1B_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target
    DiseaseBreast Cancer, prostate cancer
    Gene EnsemblENSG00000125538
    Target ClassificationCheckpoint-Immuno Oncology

    The target: IL1B, gene name: IL1B, also named as IL-1, IL1-BETA, IL1F2. The protein encoded by this gene is a member of the interleukin 1 cytokine family. This cytokine is produced by activated macrophages as a proprotein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). This cytokine is an important mediator of the inflammatory response, and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis. The induction of cyclooxygenase-2 (PTGS2/COX2) by this cytokine in the central nervous system (CNS) is found to contribute to inflammatory pain hypersensitivity. Similarly, IL-1B has been implicated in human osteoarthritis pathogenesis. Patients with severe Coronavirus Disease 2019 (COVID-19) present elevated levels of pro-inflammatory cytokines such as IL-1B in bronchial alveolar lavage fluid samples. The lung damage induced by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is to a large extent, a result of the inflammatory response promoted by cytokines such as IL-1B. This gene and eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2. [provided by RefSeq, Jul 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.